Micro- and Nanoplastics Linked to Increased Heart Attack Risk

Patients who experienced a serious heart attack were significantly more likely to have micro- and nanoplastics (MNPs) in their blood compared to those with chronic ischemic heart disease or healthy coronary arteries, according to a study published in the European Heart Journal. Researchers from Sapienza University of Rome, the University of Verona, and the University … Read more

Targeting Microglia to Extend Stroke Recovery

Researchers at the Institute of Science Tokyo have identified a molecular mechanism that causes the brain’s recovery window to close following an ischemic stroke. A study published in Nature, led by Jun Tsuyama and Takashi Shichita, reveals that the protein ZFP384 acts as a transcriptional “brake,” suppressing the reparative functions of microglia. By blocking this … Read more

Genetic Map Breakthrough Could Reverse Bone Loss

An international research team has mapped the cells and genes regulating bone formation and loss, identifying blood vessel cells as a driver of skeletal repair. Published in Nature Genetics, the study utilized genomic sequencing and data from 500,000 individuals to discover hundreds of previously unknown genes linked to bone health, offering new targets for treating … Read more

Long COVID Brain Scans Reveal Dopamine Damage and New Treatment Paths

New research published in eBioMedicine provides the strongest evidence to date that long COVID is linked to physical injury within the brain’s dopamine system. Researchers at the Centre for Addiction and Mental Health (CAMH) in Canada used PET imaging to identify reduced dopamine nerve terminal density, offering a potential biological explanation for persistent symptoms like … Read more

New AML Subgroups and Drug Sensitivities Revealed by Epigenomic Analysis

Acute myeloid leukemia (AML), a fast-growing cancer with a 29% survival rate, is being redefined by a breakthrough in epigenomic mapping. A study published in Nature by researchers at Kyoto University and the Karolinska Institute identified 16 distinct epigenomic subgroups of AML based on chromatin accessibility. This research demonstrates that chromatin architecture, rather than gene … Read more

Engineered AAVs Use Glymphatic System to Target the Brain

Researchers at the University of Rochester Medicine and the University of Copenhagen have developed a gene therapy delivery platform that uses engineered adeno-associated viruses (AAVs) and the brain’s glymphatic system to bypass the blood-brain barrier. According to a study published in Nature Biotechnology, this method successfully targets human glial progenitor cells, offering a potential pathway … Read more

AI Tool Outperforms Google in 3D RNA Shape Prediction

Researchers at Virginia Tech have developed a new artificial intelligence tool, RNAbpFlow, capable of predicting 3D RNA structures without relying on evolutionary data or homologous templates. In blind testing, the model produced a correct overall structure for 12 of 14 RNA targets, compared with eight out of 14 for AlphaFold 3, according to research published … Read more

APOE4 and Alzheimer’s Risk: New Findings in Japanese Populations

New research led by Niigata University indicates that the risk of Alzheimer’s disease associated with carrying two copies of the APOE4 gene variant is lower in Japanese populations than previously estimated. A meta-analysis published in the journal Molecular Neurodegeneration suggests that Japanese APOE4 homozygotes face a 12–15-fold increased risk of developing the disease, lower than … Read more

Parkinson’s Disease: Women Show Higher Amyloid Plaque Levels Than Men

Women diagnosed with Parkinson’s disease exhibit a higher amyloid plaque burden in the brain compared to men, according to a study led by the Mayo Clinic Arizona. While men with Parkinson’s are generally at a higher risk of developing dementia, this new research indicates that women harbor more Alzheimer’s-related protein deposits, even when adjusting for … Read more

Peptide-Based mRNA Vaccine: A New Hope for Neuroblastoma

Researchers at the RCSI University of Medicine and Health Sciences have developed a novel mRNA vaccine for neuroblastoma using self-assembling peptide nanoparticles. According to study lead Olga Piskareva, the vaccine, which targets the glypican 2 (GPC2) antigen, reduced tumor volume by 70% in murine models. This approach offers a potential alternative to traditional lipid-based delivery … Read more